Co-delivery of sorafenib and VEGF-siRNA via pH-sensitive liposomes for the synergistic treatment of hepatocellular carcinoma

Combined Treatment for Lung Metastasis from Hepatocellular Carcinoma: A Case Report

(2018) Hee-jae Jang et al.   Explore-The Journal of Science and Healing

Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy

(2018) Xingmei Duan et al.   International Journal of Nanomedicine

Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques

(2018) Yi Zhao et al.   JOURNAL OF CONTROLLED RELEASE

Tumor microenvironment dual-responsive core–shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA

(2017) Tianqi Wang et al.   International Journal of Nanomedicine

Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes

(2017) Jibin Guan et al.   Nanoscale

Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review

(2016) Manju Kanamala et al.   BIOMATERIALS

Highly efficient siRNA delivery from core–shell mesoporous silica nanoparticles with multifunctional polymer caps

(2016) Karin Möller et al.   Nanoscale

Therapeutic potential of targeted multifunctional nanocomplex co-delivery of siRNA and low-dose doxorubicin in breast cancer

(2015) Dawen Dong et al.   CANCER LETTERS

Life in 3D is never flat: 3D models to optimise drug delivery

(2015) Kathleen A. Fitzgerald et al.   JOURNAL OF CONTROLLED RELEASE

Sequential Intra-Intercellular Nanoparticle Delivery System for Deep Tumor Penetration

(2014) Caoyun Ju et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas

(2014) Zhen-Zhen Yang et al.   BIOMATERIALS

Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers

(2014) Vasilios Tsouris et al.   BIOTECHNOLOGY ADVANCES

Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids

(2014) Michael G. Wientjes et al.   JOURNAL OF CONTROLLED RELEASE

Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA

(2014) Jianan Shen et al.   MOLECULAR PHARMACEUTICS

Enhancing endosomal escape for nanoparticle mediated siRNA delivery

(2014) Da Ma   Nanoscale

The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations

(2014) Zixiu Du et al.   Scientific Reports

Predictive Models of Diffusive Nanoparticle Transport in 3-Dimensional Tumor Cell Spheroids

(2013) Yue Gao et al.   AAPS Journal

Lipid-based nanoparticles in the systemic delivery of siRNA

(2013) Qiaoya Lin et al.   Nanomedicine

The Emperor of All Maladies: A Biography of Cancer. Written by Siddhartha Mukherjee. Scribner, New York, 2011. 608pp. Price: $18.00 (US), £9.99 (UK). ISBN 978-1439170915.

(2012) David P. Yuppa   PSYCHO-ONCOLOGY

The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells

(2009) Yin-Lin Ge et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY